Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder f…
Biotechnology
US, South San Francisco [HQ]
Balance Sheet
Loading...